InvestorsHub Logo
Followers 0
Posts 165
Boards Moderated 0
Alias Born 11/22/2022

Re: None

Tuesday, 05/09/2023 6:45:08 PM

Tuesday, May 09, 2023 6:45:08 PM

Post# of 3059
The other reason 235 has no chance:

https://clinicaltrials.gov/ct2/show/NCT05580003

Not going to beat them. If a new variant comes along and seropositivity goes for naught, I believe Pfizer will win with this new compound.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News